Alzamend Neuro Inc

ALZN | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.94

+$0.05 (+2.65%)

At close: Sep 21, 2026, 4:00 PM ET

$1.93

-$0.01 (-0.46%)

Pre-market: Sep 22, 2026, 6:05 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Apr 29, 2026	FY 2025 Apr 29, 2025	FY 2024 Apr 29, 2024	FY 2023 Apr 29, 2023	FY 2022 Apr 29, 2022	FY 2021 Apr 29, 2021
Net Income	-8.77M	-4.51M	-9.95M	-14.88M	-12.36M	-5.05M
Depreciation & Amortization	110.74K	50.74K	50.74K	23.07K	3.55K	n/a
Stock-Based Compensation	707.53K	325.11K	955.63K	3.58M	4.41M	2.03M
Other Working Capital	-825.09K	-2.44M	670.67K	2.35M	633.6K	-152.45K
Other Non-Cash Items	n/a	9.29K	714	1.71M	8.77K	454.63K
Deferred Income Tax	n/a	n/a	n/a	-1.71M	n/a	n/a
Change in Working Capital	-113.7K	-2.44M	670.67K	2.35M	1.33M	-152.45K
Operating Cash Flow	-8.07M	-6.57M	-8.27M	-8.92M	-6.61M	-2.71M
Capital Expenditures	n/a	-300K	-147.24K	n/a	-106.46K	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	100.92K
Investing Cash Flow	n/a	-300K	-147.24K	n/a	-106.46K	100.92K
Debt Repayment	n/a	n/a	300K	n/a	n/a	402.11K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	600	n/a	n/a	-58.7K	1.95M
Financial Cash Flow	4.83M	10.44M	3.65M	200	18.85M	4.45M
Net Cash Flow	-3.24M	3.57M	-4.76M	-8.92M	12.13M	1.84M
Free Cash Flow	-8.07M	-6.87M	-8.42M	-8.92M	-6.72M	-2.71M
Adj. Free Cash Flow	-8.78M	-7.19M	-9.37M	-12.51M	-11.13M	-4.74M
Maintenance CapEx	n/a	-50.74K	-50.74K	n/a	-3.55K	n/a
Growth CapEx	n/a	-249.26K	-96.5K	n/a	-102.91K	n/a
Owner Earnings	-8.07M	-6.62M	-8.32M	-8.92M	-6.62M	-2.71M